Evidence map›Paper›PMID 23040478›Full record

ArticleCell stem cell2012

Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal.

Graziano Martello, Toshimi Sugimoto, Evangelia Diamanti, Anagha Joshi, Rebecca Hannah, Satoshi Ohtsuka, Berthold Göttgens, Hitoshi Niwa, Austin Smith

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cell stem cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 224 papers.

0numbers the graph read from it
0cells of the map it votes in
224citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

224 citing papers in PubMed, 390 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Glycosylation in Stem Cell Biology.Handbook of experimental pharmacology · 2025
    Review
  14. Propagating pluripotency - The conundrum of self-renewal.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

164 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Graziano MartelloWellcome Trust - Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge UK.
Toshimi Sugimoto
Evangelia Diamanti
Anagha Joshi
Rebecca Hannah
Satoshi Ohtsuka
Berthold Göttgens
Hitoshi Niwa
Austin Smith
Kobe University · JPMedical Research Council · GBUniversity of Cambridge · GBWellcome/MRC Cambridge Stem Cell Institute · GBRIKEN Center for Computational Science · JP

Funding

Biotechnology and Biological Sciences Research Council BB/H531527/1Cancer Research UK 12765Medical Research Council G0800784Medical Research Council G1001028Medical Research Council G1100526National Centre for the Replacement, Refinement and Reduction of Animals in Research G0900729/1Wellcome Trust 079249Wellcome Trust 100140
6 · The paper itself

Abstract

Inhibition of glycogen synthase kinase-3 (Gsk3) supports mouse embryonic stem cells (ESCs) by modulating Tcf3, but the critical targets downstream of Tcf3 are unclear. We analyzed the intersection between genome localization and transcriptome data sets to identify genes repressed by Tcf3. Among these, manipulations of Esrrb gave distinctive phenotypes in functional assays. Knockdown and knockout eliminated response to Gsk3 inhibition, causing extinction of pluripotency markers and loss of colony forming capability. Conversely, forced expression phenocopied Gsk3 inhibition or Tcf3 deletion by suppressing differentiation and sustaining self-renewal. Thus the nuclear receptor Esrrb is necessary and sufficient to mediate self-renewal downstream of Gsk3 inhibition. Leukaemia inhibitory factor (LIF) regulates ESCs through Stat3, independently of Gsk3 inhibition. Consistent with parallel operation, ESCs in LIF accommodated Esrrb deletion and remained pluripotent. These findings highlight a key role for Esrrb in regulating the naive pluripotent state and illustrate compensation among the core pluripotency factors.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell LineCell SurvivalEmbryonic Stem CellsGene Expression Regulation, DevelopmentalGenomeGlycogen Synthase Kinase 3Leukemia Inhibitory FactorMicePluripotent Stem CellsReceptors, EstrogenRNA, Small InterferingBasic Helix-Loop-Helix ProteinsEsrrb protein, mouseGlycogen Synthase Kinase 3Leukemia Inhibitory FactorLIF protein, humanReceptors, EstrogenRNA, Small InterferingTcf3 protein, mouse

Identifiers

PMID23040478
PMCPMC3465555
OpenAlexW2163092257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.